Volume 31, Issue 7
Free Access

Nonsteroidal Anti‐Inflammatory Drugs: Effects on Kidney Function

Dr. Andrew Whelton MD, FACP, FCP

Corresponding Author

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

The Johns Hopkins Hospital, 1830 East Monument Street, Rm 815, Baltimore, MD 21205.Search for more papers by this author
First published: July 1991
Citations: 193

Abstract

Nonsteroidal anti‐inflammatory drugs (NSAIDs) are capable of inducing a variety of renal function abnormalities, particularly in high‐risk patients with decreased renal blood perfusion who depend on prostaglandin synthesis to maintain normal renal function. Fluid retention is the most common NSAID‐related renal complication, occurring to some degree in virtually all exposed individuals; however, clinically detectable edema occurs in less than 5% of patients and is readily reversible on discontinuation of the NSAID. Other electrolyte complications, notably hyperkalemia, are seen infrequently and occur in specific at‐risk patients. The next most worrisome complication is acute deterioration of renal function, which occurs in high‐risk patients and is also reversible. Nephrotic syndrome with interstitial nephritis is a rare problem of NSAID use and is reversible. Papillary necrosis is the only permanent complication of NSAIDs and is very rare. Altogether, these renal function abnormalities, with the exception of mild fluid retention, are clinically detectable in approximately 1% of exposed patients. Given the number of patients who take NSAIDs on a prescription or over‐the‐counter basis, the absolute number of at‐risk patients is relatively large. Consequently, an appreciation for the risk factors and pathophysiology of NSAID‐induced renal function abnormalities is required for optimal use of these drugs.

Number of times cited according to CrossRef: 193

  • NSAIDs in CKD: Are They Safe?, American Journal of Kidney Diseases, 10.1053/j.ajkd.2020.03.023, (2020).
  • Pain and Chronic Kidney Disease, Chronic Renal Disease, 10.1016/B978-0-12-815876-0.00078-4, (1279-1289), (2020).
  • Drug-Drug Interactions Between Lithium and Cardiovascular as Well as Anti-Inflammatory Drugs, Pharmacopsychiatry, 10.1055/a-1157-9433, 53, 05, (229), (2020).
  • Therapeutic approaches in the treatment of gout, Seminars in Arthritis and Rheumatism, 10.1016/j.semarthrit.2020.04.010, 50, 3, (S24-S30), (2020).
  • Concomitant tacrolimus and ketorolac therapy in pediatric liver transplant recipients: Teaching old dogma new tricks, Clinical Transplantation, 10.1111/ctr.14141, 0, 0, (2020).
  • Comparative effect of Indomethacin (IndoM) on the enzymes of carbohydrate metabolism, brush border membrane and oxidative stress in the kidney, small intestine and liver of rats, Toxicology Reports, 10.1016/j.toxrep.2019.04.010, (2019).
  • Inflammation-Responsive Polymers, Smart Polymers and their Applications, 10.1016/B978-0-08-102416-4.00007-7, (219-254), (2019).
  • Ligand based Design and Synthesis of Pyrazole Based Derivatives as Selective COX-2 Inhibitors, Bioorganic Chemistry, 10.1016/j.bioorg.2019.02.031, (2019).
  • The case for cautious consumption, Current Opinion in Nephrology and Hypertension, 10.1097/MNH.0000000000000473, 28, 2, (163-170), (2019).
  • Evaluation of prescribing patterns of nonsteroidal anti-inflammatory agents in a tertiary setting, International Journal of Evidence-Based Healthcare, 10.1097/XEB.0000000000000173, 17, 3, (164-172), (2019).
  • Need for a Judicious Use of Nonsteroidal Anti-inflammatory Drugs to Avoid Community-Acquired Acute Kidney Injury, Annals of Pharmacotherapy, 10.1177/1060028018789174, 53, 1, (95-100), (2018).
  • Maligned non-steroidal anti-inflammatory drugs: Misunderstanding of their safety profile in patients with renal insufficiency, World Journal of Rheumatology, 10.5499/wjr.v8.i1.1, 8, 1, (1-4), (2018).
  • Low rates of renal injury in total joint arthroplasty patients without pre-existing renal disease, Arthroplasty Today, 10.1016/j.artd.2017.12.007, (2018).
  • Nephrotoxicity of Select Rheumatologic Drugs, Rheumatic Disease Clinics of North America, 10.1016/j.rdc.2018.06.005, 44, 4, (605-617), (2018).
  • Nonopioid Analgesics, Essentials of Pain Medicine, 10.1016/B978-0-323-40196-8.00051-6, (457-468.e2), (2018).
  • Efficacy and safety of ChondroT on knee-osteoarthritis, Medicine, 10.1097/MD.0000000000010170, 97, 12, (e0170), (2018).
  • Targeting lipid mediators in cancer biology, Cancer and Metastasis Reviews, 10.1007/s10555-018-9754-9, 37, 2-3, (557-572), (2018).
  • Spinal Manipulative Therapy and Other Conservative Treatments for Low Back Pain: A Guideline From the Canadian Chiropractic Guideline Initiative, Journal of Manipulative and Physiological Therapeutics, 10.1016/j.jmpt.2017.12.004, 41, 4, (265-293), (2018).
  • Safer anti-inflammatory therapy through dual COX-2/5-LOX inhibitors: A structure-based approach, European Journal of Pharmaceutical Sciences, 10.1016/j.ejps.2018.06.003, 121, (356-381), (2018).
  • Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database, SAGE Open Medicine, 10.1177/2050312118772475, 6, (205031211877247), (2018).
  • Is low dose radiotherapy an effective treatment for Baker’s cyst?Ist die Strahlentherapie eine effektive Behandlungsoption der Bakerzyste?, Strahlentherapie und Onkologie, 10.1007/s00066-018-1389-9, (2018).
  • Omega-3 PUFA vs. NSAIDs for Preventing Cardiac Inflammation, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2018.00146, 5, (2018).
  • Terminalia bellirica (Gaertn.) Roxb fruit exerts anti-inflammatory effect via regulating arachidonic acid pathway and pro-inflammatory cytokines in lipopolysaccharide-induced RAW 264.7 macrophages, Inflammopharmacology, 10.1007/s10787-018-0513-x, (2018).
  • Prevalence of pain medication prescriptions in France, Germany, and the UK - a cross-sectional study including 4,270,142 patients, Postgraduate Medicine, 10.1080/00325481.2018.1391658, 130, 1, (32-36), (2017).
  • Sedation and Analgesia, Pharmaceutical Sciences, 10.4018/978-1-5225-1762-7, (486-519), (2017).
  • Paracetamol: overdose-induced oxidative stress toxicity, metabolism, and protective effects of various compounds in vivo and in vitro , Drug Metabolism Reviews, 10.1080/03602532.2017.1354014, 49, 4, (395-437), (2017).
  • NSAIDs and Cardiovascular Toxicity ☆, Reference Module in Biomedical Sciences, 10.1016/B978-0-12-801238-3.95640-X, (2017).
  • Risk of perioperative bleeding related to highly selective cyclooxygenase-2 inhibitors: A systematic review and meta-analysis, Seminars in Arthritis and Rheumatism, 10.1016/j.semarthrit.2016.07.008, 46, 4, (520-528), (2017).
  • Acute Pain Management: Operative or Medical Procedures and Trauma, Annals of Pharmacotherapy, 10.1177/106002809703100917, 31, 9, (1068-1076), (2017).
  • Nonnarcotic Analgesics: Prevalence and Estimated Economic Impact of Toxicities, Annals of Pharmacotherapy, 10.1177/106002809703100214, 31, 2, (221-227), (2017).
  • Cyclooxygenase-2 inhibitor-induced acute interstitial nephritis, BMJ Case Reports, 10.1136/bcr-2017-219973, (bcr-2017-219973), (2017).
  • Mechanisms of triple whammy acute kidney injury, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2016.07.011, 167, (132-145), (2016).
  • Evaluation of anti-inflammatory, analgesic activities, and side effects of some pyrazole derivatives, Inflammopharmacology, 10.1007/s10787-016-0270-7, 24, 4, (163-172), (2016).
  • Zomepirac Acyl Glucuronide Is Responsible for Zomepirac-Induced Acute Kidney Injury in Mice, Drug Metabolism and Disposition, 10.1124/dmd.116.069575, 44, 7, (888-896), (2016).
  • Chemical-Induced Nephropathy: A Review of the Renal Tubulointerstitial Lesions in Humans, Toxicologic Pathology, 10.1080/01926230490457530, 32, 2_suppl, (71-84), (2016).
  • The Renal Effects of Traditional Nonsteroidal Anti-Inflammatory Agents Versus Cyclooxygenase-2 Inhibitors, Journal of Pharmacy Practice, 10.1177/089719002237254, 15, 5, (383-391), (2016).
  • Normal Ultrastructure of the Kidney and Lower Urinary Tract, Toxicologic Pathology, 10.1177/019262339802600101, 26, 1, (1-17), (2016).
  • Renal Papillary Necrosis—40 Years On, Toxicologic Pathology, 10.1177/019262339802600110, 26, 1, (73-91), (2016).
  • Interspecies Differences in Renal Localization of Cyclooxygenase Isoforms: Implications in Nonsteroidal Antiinflammatory Drug-Related Nephrotoxicity, Toxicologic Pathology, 10.1177/019262339802600504, 26, 5, (612-620), (2016).
  • Effect of Papillotoxic Agents on Expression of Cyclooxygenase Isoforms in the Rat Kidney, Toxicologic Pathology, 10.1177/019262339802600116, 26, 1, (137-142), (2016).
  • Sedation and Analgesia, Modern Concepts and Practices in Cardiothoracic Critical Care, 10.4018/978-1-4666-8603-8.ch012, (278-312), (2015).
  • Pain and Chronic Kidney Disease, Chronic Renal Disease, 10.1016/B978-0-12-411602-3.00071-8, (854-860), (2015).
  • Risks associated with drug treatments for kidney stones, Expert Opinion on Drug Safety, 10.1517/14740338.2015.1100604, 14, 12, (1865-1877), (2015).
  • Evaluation of diuretic activity of Syzygium cumini and its effect on prostaglandin system, Oriental Pharmacy and Experimental Medicine, 10.1007/s13596-015-0179-5, 15, 1, (45-51), (2015).
  • Inhibition of cyclooxygenase-2 in hematopoietic cells results in salt-sensitive hypertension, Journal of Clinical Investigation, 10.1172/JCI81550, 125, 11, (4281-4294), (2015).
  • Topical Nonsteroidal Anti-Inflammatory Drugs for Osteoarthritis, Postgraduate Medicine, 10.3810/pgm.2010.11.2227, 122, 6, (98-106), (2015).
  • Tips for managing chronic pain, Postgraduate Medicine, 10.3810/pgm.2003.04.1400, 113, 4, (49-98), (2015).
  • Effective management of chronic pain, Postgraduate Medicine, 10.3810/pgm.1996.09.82, 100, 3, (281-296), (2015).
  • NSAIDs Alter Phosphorylated Forms of AQP2 in the Inner Medullary Tip, PLOS ONE, 10.1371/journal.pone.0141714, 10, 10, (e0141714), (2015).
  • Renal pathology associated with kidney stones in two buffaloes, Veterinary Medicine and Animal Sciences, 1072432054342531, 3, 1, (1), (2015).
  • Risk Factors for Acute Kidney Injury in Adult Patients Receiving Vancomycin, Clinical Drug Investigation, 10.1007/s40261-013-0163-0, 34, 3, (189-193), (2014).
  • Outpatient management of biliary colic: A prospective observational study of prescribing habits and analgesia effectiveness, International Journal of Surgery, 10.1016/j.ijsu.2013.12.003, 12, 2, (169-176), (2014).
  • The case for over-the-counter shortwave therapy: safe and effective devices for pain management, Pain Management, 10.2217/pmt.13.60, 4, 1, (37-43), (2014).
  • Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects, European Journal of Clinical Pharmacology, 10.1007/s00228-014-1734-6, 70, 10, (1159-1172), (2014).
  • A multicenter, randomized, controlled trial to evaluate the safety profile, tolerability, and efficacy of rofecoxib in advanced elderly patients with osteoarthritis, Aging Clinical and Experimental Research, 10.1007/BF03351533, 13, 2, (112-121), (2014).
  • Pain Treatment With NSAIDs, Primary Focus on Ibuprofen, Clinical Rheumatology, 10.1007/BF03342661, 20, S1, (6-8), (2014).
  • The Burden of Nephrotoxic Drug Prescriptions in Patients with Chronic Kidney Disease: A Retrospective Population-Based Study in Southern Italy, PLoS ONE, 10.1371/journal.pone.0089072, 9, 2, (e89072), (2014).
  • The Anti-Arthritic and Immune-Modulatory Effects of NHAG: A Novel Glucosamine Analogue in Adjuvant-Induced Arthritis, BioMed Research International, 10.1155/2013/487610, 2013, (1-13), (2013).
  • The renal injury and inflammation caused by ischemia–reperfusion are reduced by genetic inhibition of TNF-αR1: A comparison with infliximab treatment, European Journal of Pharmacology, 10.1016/j.ejphar.2012.11.066, 700, 1-3, (134-146), (2013).
  • Life-threatening hyperkalemia after 2 days of ibuprofen, The American Journal of Emergency Medicine, 10.1016/j.ajem.2012.09.002, 31, 2, (465.e1-465.e2), (2013).
  • Classification of Nephrotoxicants, Kidney, 10.1201/b15476, (191-203), (2013).
  • Analgesic Effect of Sustained‐Release Flurbiprofen Administered at the Site of Tissue Injury in the Oral Surgery Model, The Journal of Clinical Pharmacology, 10.1177/0091270004265703, 44, 12, (1418-1424), (2013).
  • Analgesic Efficacy and Pharmacokinetics of Ketoprofen Administered into a Surgical Site, The Journal of Clinical Pharmacology, 10.1177/00912709922007679, 39, 2, (131-138), (2013).
  • Use of Angiotensin‐Converting Enzyme Inhibitors as Monotherapy and in Combination with Diuretics and Calcium Channel Blockers, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1998.tb05784.x, 38, 6, (477-491), (2013).
  • Renal Effects of Over‐the‐Counter Analgesics, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1995.tb04088.x, 35, 5, (454-463), (2013).
  • Clinical Therapeutic Conference, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1991.tb01911.x, 31, 9, (785-791), (2013).
  • Interdisziplinäre Handlungsempfehlung zum Management von Schmerzen bei älteren Menschen in PflegeheimenInterdisciplinary guidance for pain management in nursing home residents, Zeitschrift für Gerontologie und Geriatrie, 10.1007/s00391-012-0332-4, 45, 6, (505-544), (2012).
  • Genomic biomarkers for chronic kidney disease, Translational Research, 10.1016/j.trsl.2012.01.020, 159, 4, (290-302), (2012).
  • Renal Consequences of Prostaglandin Inhibition in Heart Failure, The Kidney in Heart Failure, 10.1007/978-1-4614-3694-2, (117-125), (2012).
  • Pharmacogenetics of nonsteroidal anti-inflammatory drugs, The Pharmacogenomics Journal, 10.1038/tpj.2012.40, 12, 6, (462-467), (2012).
  • 5-Lipoxygenase Metabolic Contributions to NSAID-Induced Organ Toxicity, Advances in Therapy, 10.1007/s12325-011-0100-7, 29, 2, (79-98), (2012).
  • Osteoarthritis in the cat, Journal of Feline Medicine and Surgery, 10.1177/1098612X11432829, 14, 1, (76-84), (2012).
  • Alteraciones de la potasemia en el adulto, EMC - Anestesia-Reanimación, 10.1016/S1280-4703(12)60582-9, 38, 1, (1-15), (2012).
  • Hyperkalaemia in the age of aldosterone antagonism, QJM, 10.1093/qjmed/hcs106, 105, 11, (1049-1057), (2012).
  • Dispensed Selective and Nonselective Nonsteroidal Anti-inflammatory Drugs and the Risk of Moderate to Severe Hyperkalemia: A Nested Case-Control Study, American Journal of Kidney Diseases, 10.1053/j.ajkd.2012.02.328, 60, 1, (82-89), (2012).
  • Nonoperative Treatment of Knee Arthritis, Insall & Scott Surgery of the Knee, 10.1016/B978-1-4377-1503-3.00092-5, (896-908), (2012).
  • Indomethacin Reduces Glomerular and Tubular Damage Markers but Not Renal Inflammation in Chronic Kidney Disease Patients: A Post-Hoc Analysis, PLoS ONE, 10.1371/journal.pone.0037957, 7, 5, (e37957), (2012).
  • Sodium Diclofenac and Cell-Penetrating Peptides Embedded in H II Mesophases: Physical Characterization and Delivery , The Journal of Physical Chemistry B, 10.1021/jp112067v, 115, 34, (10189-10197), (2011).
  • Cyclooxygenase-2-dependent phosphorylation of the pro-apoptotic protein Bad inhibits tonicity-induced apoptosis in renal medullary cells, Kidney International, 10.1038/ki.2011.199, 80, 9, (938-945), (2011).
  • PHARMACOLOGY AND DRUG THERAPY, Textbook of Pediatric Rheumatology, 10.1016/B978-1-4160-6581-4.10006-8, (71-126), (2011).
  • Risk factors for acute kidney injury by non-steroidal anti-inflammatory drugs in patients with hyperuricaemia, Rheumatology, 10.1093/rheumatology/ker286, 50, 12, (2278-2282), (2011).
  • Adverse Drug Reactions and Drug-drug Interactions, Pediatric Critical Care, 10.1016/B978-0-323-07307-3.10118-1, (1569-1589), (2011).
  • Dyskaliémies de l'adulte, EMC - Anesthésie-Réanimation, 10.1016/S0246-0289(11)44765-4, 8, 4, (1-15), (2011).
  • Glutamine contributes to ameliorate inflammation after renal ischemia/reperfusion injury in rats, Naunyn-Schmiedeberg's Archives of Pharmacology, 10.1007/s00210-011-0610-5, 383, 5, (493-508), (2011).
  • The effect of single-dose non-steroidal anti-inflammatory drugs on urinary output, Clinical Intensive Care, 10.3109/tcic.10.2.55.60, 10, 2, (55-60), (2011).
  • Analgesics and Nonsteroidal Anti-Inflammatory Drugs, Comprehensive Toxicology, 10.1016/B978-0-08-046884-6.00821-6, (387-403), (2010).
  • NSAIDs and Cardiovascular Toxicity, Comprehensive Toxicology, 10.1016/B978-0-08-046884-6.00716-8, (323-336), (2010).
  • Non-steroidal anti-inflammatory drugs: use and co-treatment with potentially interacting medications in the elderly, European Journal of Clinical Pharmacology, 10.1007/s00228-010-0825-2, 66, 8, (823-829), (2010).
  • Drug-induced acute kidney injury in the critically ill adult: Recognition and prevention strategies, Critical Care Medicine, 10.1097/CCM.0b013e3181de0c60, 38, (S169-S174), (2010).
  • AJC Editor's Consensus: Selective and Nonselective Nonsteroidal Anti-Inflammatory Drugs and Cardiovascular Risk, The American Journal of Cardiology, 10.1016/j.amjcard.2010.04.006, 106, 6, (873-884), (2010).
  • A Call for Rational and Cost-Effective NSAID Therapy , Journal of Pharmaceutical Care in Pain & Symptom Control, 10.1300/J088v02n02_05, 2, 2, (39-46), (2010).
  • Diclofenac Sodium Gel in Patients with Primary Hand Osteoarthritis: A Randomized, Double-blind, Placebo-controlled Trial, The Journal of Rheumatology, 10.3899/jrheum.081316, 36, 9, (1991-1999), (2009).
  • Renal adverse effects of nonsteroidal anti-inflammatory drugs, Expert Opinion on Drug Safety, 10.1517/14740330903311023, 8, 6, (669-681), (2009).
  • Natriuretic and diuretic effects of Tropaeolum majus (Tropaeolaceae) in rats, Journal of Ethnopharmacology, 10.1016/j.jep.2009.01.021, 122, 3, (517-522), (2009).
  • Pain management in patients with chronic kidney disease, Clinical Kidney Journal, 10.1093/ndtplus/sfp001, 2, 2, (111-118), (2009).
  • A placebo and active comparator-controlled trial of rofecoxib for the treatment of rheumatoid arthritis, Scandinavian Journal of Rheumatology, 10.1080/030097402320318431, 31, 4, (230-238), (2009).
  • Drug-Induced Acute Interstitial Nephritis, Renal Failure, 10.3109/08860229809045178, 20, 6, (809-819), (2009).
  • Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis, Journal of Thrombosis and Thrombolysis, 10.1007/s11239-008-0264-4, 27, 1, (11-17), (2008).
  • Non-steroidal anti-inflammatory drugs, Clinical Nephrotoxins, 10.1007/978-0-387-84843-3, (419-457), (2008).
  • Anti-inflammatory Botanicals A Case Study Of Genetic Screens As Part Of A Pharmacogenomic Approach, Phytochemicals, 10.1201/9781420061383, (77-87), (2008).
  • See more